References
Savona MR, Malcovati L, Komrokji R, Tiu RV, Mughal TI, Orazi A, Kiladjian JJ, Padron E, Solary E, Tibes R, Itzykson R, Cazzola M, Mesa R, Maciejewski J, Fenaux P, Garcia-Manero G, Gerds A, Sanz G, Niemeyer CM, Cervantes F, Germing U, Cross NC, List AF, Group MMIW (2015) An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. Blood 125(12):1857–1865. https://doi.org/10.1182/blood-2014-10-607341
Malcovati L, Hellström-Lindberg E, Bowen D, Adès L, Cermak J, del Cañizo C, Della Porta MG, Fenaux P, Gattermann N, Germing U, Jansen JH, Mittelman M, Mufti G, Platzbecker U, Sanz GF, Selleslag D, Skov-Holm M, Stauder R, Symeonidis A, van de Loosdrecht AA, de Witte T, Cazzola M (2013) Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 122(17):2943–2964
Lindsley RC, Ebert BL (2013) Molecular pathophysiology of myelodysplastic syndromes. Annu Rev Pathol 8(1):21–47
Pellagatti A, Boultwood J (2015) The molecular pathogenesis of the myelodysplastic syndromes. Eur J Haematol 95(1):3–15
Dalle IA, DiNardo CD (2018) The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia. Ther Adv Hematol 9(7):163–173
DiNardo CD, Jabbour E, Ravandi F, Takahashi K, Daver N, Routbort M, Patel KP, Brandt M, Pierce S, Kantarjian H, Garcia-Manero G (2016) IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression. Leukemia 30(4):980–984
Acknowledgements
We thank Dr. Marilisa Marinelli for technical support.
Funding
The study was funded by grants from AIRC.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rosso, V., Petiti, J., Dragani, M. et al. Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes. Ann Hematol 99, 891–893 (2020). https://doi.org/10.1007/s00277-020-03913-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-03913-x